Shareholders' equity · 2011–2025
Emergent Biosolutions shareholders' equity
$523M+8.2% · FY2025
Emergent Biosolutions (EBS) reported $523M in shareholders' equity for fiscal 2025, +8.2% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $523M | +8.2% | Open → |
| FY20242024-12-31 | $483M | −25.6% | Open → |
| FY20232023-12-31 | $649M | −53.2% | Open → |
| FY20222022-12-31 | $1.4B | −13.9% | Open → |
| FY20212021-12-31 | $1.6B | +11.1% | Open → |
| FY20202020-12-31 | $1.5B | +33.0% | Open → |
| FY20192019-12-31 | $1.1B | +8.0% | Open → |
| FY20182018-12-31 | $1.0B | +10.8% | Open → |
| FY20172017-12-31 | $912M | +53.0% | Open → |
| FY20162016-12-31 | $596M | −9.7% | Open → |
| FY20152015-12-31 | $660M | +19.3% | Open → |
| FY20142014-12-31 | $553M | +13.0% | Open → |
| FY20132013-12-31 | $490M | +10.9% | Open → |
| FY20122012-12-31 | $441M | +6.5% | Open → |
| FY20112011-12-31 | $414M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +1.7%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions shareholders' equity |url=https://companiesranked.com/en/company/emergent-biosolutions/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/shareholders-equityBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001367644-26-000082 · August 6, 2026
{{cite web |title=Emergent Biosolutions shareholders' equity — 10-Q (0001367644-26-000082) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000082/ebs-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.